Skip to main content
SpringerLink
Log in

Hematologic Problems of Dialysis Patients

  • Chapter
Replacement of Renal Function by Dialysis

Abstract

The kidney has a unique relationship to red cell production because of its production of the hormone erythropoietin (ESF). The development of anemia in almost all patients with chronic renal failure, therefore, is not surprising and is a major factor in preventing total rehabilitation with maintenance dialysis therapy. Several detailed reviews of erythropoietin have been published recently (1–4).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Fried W: Erythropoietin and the kidney. Nephron 15: 327, 1975.

    Article  PubMed  CAS  Google Scholar 

  2. Graber, SE, Krantz SB: Erythropoietin and the control of red cell production. Annu Rev Med 29: 51, 1978

    Article  PubMed  CAS  Google Scholar 

  3. Krantz WB: Recent contributions to the mechanism of action and clinical relevance of erythropoietin. J Lab Clin Med 82: 847, 1973

    PubMed  CAS  Google Scholar 

  4. Fisher JW: Prostaglandins and kidney erythropoietin production. Editorial review. Nephron 25: 53, 1980

    Article  PubMed  CAS  Google Scholar 

  5. Adamson JW, Eschbach JW, Finch CA: The kidney and erythropoiesis. Am J Med 44: 725, 1968

    Article  PubMed  CAS  Google Scholar 

  6. Shaw AB: Haemolysis in chronic renal failure. Br Med J 2: 213, 1967

    Article  PubMed  CAS  Google Scholar 

  7. McDermott FT, Galbraith AJ, Corlett RJ: Inhibition of cell proliferation in renal failure and its significance to the uraemic syndrome: A review. Scott Med J 20: 317, 1973

    Google Scholar 

  8. Wallner SF, Vautrin RM: The anemia of chronic renal failure. Studies of iron transport in vitro. J Lab Clin Med 96: 67, 1980

    PubMed  CAS  Google Scholar 

  9. Naets JP, Heuse AF: Measurement of erythropoietic stimulating factor in anemic patients with or without renal disease. J Lab Clin Med 60: 365, 1962

    PubMed  CAS  Google Scholar 

  10. Caro J, Brown S, Miller O, Murray T, Erslev AJ: Erythropoietin levels in uremic nephric and anephric patients. J Lab Clin Med 93: 449, 1979

    PubMed  CAS  Google Scholar 

  11. Mirand EA, Murphy GP, Steeves RA, Groenewald JM, DeKlerk JN: Erythropoietin activity in anephric, allotransplanted, unilaterally nephrectomized and intact man. J Lab Clin Med 73: 121, 1969

    PubMed  CAS  Google Scholar 

  12. Fisher JW, Stuckey WJ, Lindholm DD, Abshire S: Extrarenal erythropoietin production. Israel J Med Sci 7:991, 1971

    Google Scholar 

  13. Finch CA, Deubelbeiss K, Cook JD, Eschbach JW, Harker LA, Funk DD, Marsaglia G, Hillman RS, Slichter S, Adamson JW, Ganzoni A, Giblett ER: Ferrokinetics in man. Medicine 49: 17, 1970

    Article  PubMed  CAS  Google Scholar 

  14. Eschbach JW, Adamson JW, Cook JD: Disorders of red blood cell production in uremia. Arch Intern Med 126: 812, 1970

    Article  PubMed  CAS  Google Scholar 

  15. Eschbach JW, Detter JC, Adamson JW. Physiologic studies in normal and uremic sheep. II. Changes in erythropoiesis and oxygen transport. Kidney Int 18: 732, 1980

    Article  PubMed  CAS  Google Scholar 

  16. Radtke HW, Claussner A, Erbes PM, Scheuermann EH, Schoeppe W, Koch KM: Serum erythropoietin concentration in chronic renal failure: Relationship to degree of anemia and excretory renal function. Blood 54: 877, 1979

    PubMed  CAS  Google Scholar 

  17. Dagher FJ, Ramos E, Erslev AJ, Alongi SV, Karmi SA, Caro J: Are the native kidneys responsible for erythrocytosis in renal allorecipients? Transplantation 28: 496, 1979

    PubMed  CAS  Google Scholar 

  18. Stewart JH: Haemolytic anaemia in acute and chronic renal failure. Q J Med 36: 85, 1967

    Google Scholar 

  19. Lieberman E, Heuser E, Donnell GN, Landing BH, Hammond GD: Hemolytic-uremic syndrome. Clinical and pathological considerations. N Engl J Med 275: 227, 1966

    Article  PubMed  CAS  Google Scholar 

  20. Fisher JW: Mechanism of the anemia of chronic renal failure. Nephron 25: 106, 1980

    Article  PubMed  CAS  Google Scholar 

  21. Zucker S, Lysik RM, Mohammad G. Erythropoiesis in chronic renal disease. J Lab Clin Med 88: 528, 1976

    PubMed  CAS  Google Scholar 

  22. Charles G, Lundin AP III, Manis T, Delano BG, Joshi T, Rao TKS, Friedman EA: Surprisingly high hematocrit during maintenance hemodialysis. Kidney int 19: 144, 1981

    Google Scholar 

  23. Anagnostou A, Barone J, Kedo A, Fried W: Effect of erythropoietin therapy on the red cell volume of uraemic and non-uraemic rats. Br J Haematol 37: 85, 1977

    PubMed  CAS  Google Scholar 

  24. Van Stone JC, Max P: Effect of erythropoietin on anemia of peritoneally dialyzed anephric rats. Kidney Int 15: 370, 1979

    Article  PubMed  Google Scholar 

  25. Eschbach JW, Adamson JW: Correction by erythropoietin therapy of the anemia of chronic renal failure in sheep. Clin Res 29: 518A, 1981

    Google Scholar 

  26. Miyake T, Kung CK-H, Goldwasser E: Purification of human erythropoietin. J Biol Chem 252: 5558, 1977

    PubMed  CAS  Google Scholar 

  27. Garcia JF, Sherwood J, Goldwasser E: Radioimmunoassay of erythropoietin. Blood Cells 5: 405, 1979

    PubMed  CAS  Google Scholar 

  28. Kolk-Vegter AJ, Kolk AHJ: Some problems concerning the assay of erythropoietin using the haemagglutination inhibition kit. Br J Haematol 30: 371, 1975

    Article  PubMed  CAS  Google Scholar 

  29. Lertora JJL, Dargon PA, Rege AB, Fisher JW: Studies on a radioimmunoassay for human erythropoietin. J Lab Clin Med 86: 140, 1975

    PubMed  CAS  Google Scholar 

  30. Horowitz HI: Uremic toxins and platelet function. Arch Intern Med 126: 823, 1970

    Article  PubMed  CAS  Google Scholar 

  31. Castaldi PA, Rozenberg MC, Stewart JH: The bleeding disorder of uraemia. Lancet 2: 66, 1966

    Article  PubMed  CAS  Google Scholar 

  32. Von Hartitzsch B, Carr D, Kjellstrand CM, Kerr DNS: Normal red cell survival in well-dialyzed patients. Trans Am Soc Artif Intern Organs 19: 471, 1973

    Google Scholar 

  33. Eschbach JW Jr, Funk D, Adamson J, Kuhn I, Scribner BH, Finch CA: Erythropoiesis in patients with renal failure undergoing chronic dialysis. N Engl J Med 276: 653, 1967

    Article  PubMed  Google Scholar 

  34. Eschbach JW, Korn D, Finch CA: 14C cyanate as a tag for red cell survival in normal and uremic man. J Lab Clin Med 89: 823, 1977

    PubMed  CAS  Google Scholar 

  35. Blumberg A, Jarti HR: Red cell metabolism and haemolysis in patients on dialysis. Proc Eur Dial Transpl Assoc 9: 91, 1972

    CAS  Google Scholar 

  36. Koch KM, Patya WD, Shaldon S, Werner E: Anemia of the regular hemodialysis patient and its treatment. Nephron 12: 405, 1974

    Article  PubMed  CAS  Google Scholar 

  37. Müller-Wiefel DE, Sinn H, Gilli G, Schärer K: Hemolysis and blood loss in children with chronic renal failure. Clin Nephrol 8: 481, 1977

    PubMed  Google Scholar 

  38. Yen MC, Ball JH, Lowrie EG, Lazarus JM, Hampers CL, Merrill JP: The effect of androgens and dialysis on erythropoiesis in chronic renal failure. Proc Dial Clin Transpl Forum 3: 33, 1973

    CAS  Google Scholar 

  39. Roxe DM, del Greco F, Hughes J, Krumlovsky F, Ghantous W, Ivanovich P, Quintanilla A, Salkin M, Stone NJ, Reins M: Hemodialysis vs peritoneal dialysis: Results of a 3-year prospective controlled study Kidney Int 19: 341, 1981

    Article  PubMed  CAS  Google Scholar 

  40. Goldsmith HJ, Forbes A, Gyde OHB, Summerfield G: Hematologic aspects of continuous ambulatory peritoneal dialysis. Continuous Ambulatory Peritoneal Dialysis Proc Int Symp, Paris, nov 2 and 3 1970, edited by Legrain M, Amsterdam, Oxford, Princeton, Excerpta Medica, 1980, p 302

    Google Scholar 

  41. Madden MA, Zimmerman SW, Simpson DP: Longitudinal comparison of chronic intermittent and continuous ambulatory peritoneal dialysis. Kidney Int 19: 153, 1981

    Google Scholar 

  42. Lindsay RM, Burton JA, Dargie HJ, Prentice CRM, Kennedy AC: Dialyzer blood loss. Clin Nephrol 1: 24, 1973

    PubMed  CAS  Google Scholar 

  43. Haskins D, Stevens AR Jr, Finch S, Finch CA: Iron metabolism. Iron stores in man as measured by phlebotomy. J Clin Invest 31: 543, 1952

    Article  PubMed  CAS  Google Scholar 

  44. Fong TP, Smith EC, Thomas W Jr, Westerman MP: Diagnostic significance of bone marrow biopsy in chronic renal disease. Nephron 12: 81, 1974

    Article  PubMed  CAS  Google Scholar 

  45. Miles LEM, Lipschitz DA, Bieber CP, Cook JD: Measurement of serum ferritin by a 2-site immunoradiometric assay. Anal Biochem 61: 209, 1974

    Article  PubMed  CAS  Google Scholar 

  46. Mirahmadi KS, Wellington LP, Winer RL, Dabir-Vaziri N, Byer B, Gorman JT, Rosen SM: Serum ferritin level. Determinant of iron requirement in hemodialysis patients. JAMA 238: 601, 1977

    Article  PubMed  CAS  Google Scholar 

  47. Bell JD, Kincaid WR, Morgan RG, Bunce III H, Alperin JB, Searles HE, Remmers AR Jr: Serum ferritin assay and bone-marrow iron stores in patients on maintenance hemodialysis. Kidney Int 17: 237, 1980

    Article  PubMed  CAS  Google Scholar 

  48. Aljama P, Ward MK, Pierides AM, Eastham EJ, Ellis HA, Feest TG, Conceicao S, Kerr DNS: Serum ferritin concentration: A reliable guide to iron overload in uremic and hemodialyzed patients. Clin Nephrol 10: 101, 1978.

    PubMed  CAS  Google Scholar 

  49. Gokal R, Millard PR, Weatherall DJ, Callender STE, Ledingham G, Oliver DO: Iron metabolism in haemodialysis patients. Q J Med 158: 369, 1979

    Google Scholar 

  50. Eschbach JW, Cook JD, Scribner BH, Finch CA: Iron balance in hemodialysis patients. Ann Intern Med 87:710,

    Google Scholar 

  51. Hussein S, Prieto J, O’Shea M, Hoffbrand AV, Baillod RA, Moorhead JF: Serum ferritin assay and iron status in chronic renal failure and haemodialysis. Br Med J 1:546,

    Google Scholar 

  52. Beallo R, Dallman PR, Schoenfeld PY, Humphreys MH: Serum ferritin and iron deficiency in patients on chronic hemodialysis. Trans Am Soc Artif Intern Organs 22:73,

    Google Scholar 

  53. Dallman PR, Beutler E, Finch CA: Effects of iron deficiency exclusive of anaemia. Br J Haematol 40:179,

    Google Scholar 

  54. Whitehead VM, Comty CH, Posen GA, Kaye M: Homeostasis of folic acid in patients undergoing maintenance hemodialysis. N Engl J Med 279: 970, 1980

    Article  Google Scholar 

  55. Hemmeløff Andersen KE: Folic acid status of patients with chronic renal failure maintained by dialysis. Clin Nephrol 8: 510, 1977

    PubMed  Google Scholar 

  56. Hampers CL, Streiff R, Nathan DG, Snyder D, Merrill JP: Megaloblastic hematopoiesis in uremia and in patients on long-term hemodialysis. N Engl J Med 276: 551, 1967

    Article  PubMed  CAS  Google Scholar 

  57. Siddiqui J, Freeburger R, Freeman RM: Folic acid, hypersegmented polymorphonuclear leukocyte and the uremic syndrome. Am J Clin Nutr 23: 11, 1970

    PubMed  CAS  Google Scholar 

  58. Eichner ER, Paine CJ, Dickson VL, Hargrove MD Jr: Clinical and laboratory observations on serum folatebinding protein. Blood 46: 599, 1975

    PubMed  CAS  Google Scholar 

  59. Matter BJ, Pederson J, Psimenos G, Lindeman RD: Lethal copper intoxication in hemodialysis. Trans Am Soc Artif Intern Organs 15: 309, 1969

    PubMed  CAS  Google Scholar 

  60. Ivanovich P, Manzler A, Drake R: Acute hemolysis following hemodialysis. Trans Am Soc Artif Intern Organs 15: 316, 1969

    PubMed  CAS  Google Scholar 

  61. Manzler AD, Schreiner AW: Copper-induced acute hemolytic anemia. A new complication of hemodialysis. Ann Intern Med 73: 409, 1970.

    PubMed  CAS  Google Scholar 

  62. Boulard M, Blume K-G, Beutler E: The effect of copper on red cell enzyme activities. J Clin Invest 51: 459, 1972

    Article  PubMed  CAS  Google Scholar 

  63. Yawata Y, Howe R, Jacob HS: Abnormal red cell metabolism causing hemolysis in uremia. A defect potentiated by tap water hemodialysis. Ann Intern Med 79: 362, 1973

    PubMed  CAS  Google Scholar 

  64. Eaton JW, Leida MN, Kjellstrand CM, Jacob HS: Oxidant-induced erythrocyte destruction in chronic renal disease. Proc 12th Annu Contractors’Conf Artif Kidney Program, NIAMDD, edited by Mackey BB NIH Publ No 81-1979, 1981, p 105

    Google Scholar 

  65. Higgins MR, Grace M, Ulan RA, Silverberg DS, Bettcher KB, Dossetor JB: Anemia in hemodialysis patients. Arch Intern Med 137: 172, 1977

    Article  PubMed  CAS  Google Scholar 

  66. Neilan BA, Ehlers SM, Kolpin CF, Eaton JW: Prevention of chloramine-induced hemolysis in dialyzed patients. Clin Nephrol 10: 105, 1978

    PubMed  CAS  Google Scholar 

  67. Botella J, Traver JA, Sanz-Guajardo D, Torres MT, Sanjuan I, Zabala P: Chloramines, an aggravating factor in the anaemia of patients on regular dialysis treatment. Proc Eur Dial Transpl Assoc 14: 192, 1977

    CAS  Google Scholar 

  68. Carlson DJ, Shapiro FL: Methemoglobinemia from well water nitrates: A complication of home dialysis. Ann Intern Med 73: 757, 1970

    PubMed  CAS  Google Scholar 

  69. Orringer EP, Mattern WD: Formaldehyde-induced hemolysis during chronic hemodialysis. N Engl J Med 294: 1416, 1976

    Article  PubMed  CAS  Google Scholar 

  70. Howell ED, Perkins HA: Anti-N-like antibodies in the sera of patients undergoing chronic hemodialysis. Vox Sang 23: 291, 1972

    Article  PubMed  CAS  Google Scholar 

  71. Shaldon S, Chevallet M, Maraoui M, Mion C: Dialysis associated autoantibodies. Proc Eur Dial Transpl Assoc 13: 339, 1976

    Google Scholar 

  72. Kaehny WD, Miller GE, White WL: Relationship between dialyzer reuse and the presence of anti-N-like antibodies in chronic hemodialysis patients. Kidney Int 12: 59, 1977

    Article  PubMed  CAS  Google Scholar 

  73. Koch KM, Fei U, Fassbinder W: Hemolysis and anemia in anti-N-like antibody positive hemodialysis patients. Trans Am Soc Artif Intern Organs 24: 709, 1978

    PubMed  CAS  Google Scholar 

  74. Fassbinder W, Pilar J, Scheuermann E, Koch M: Formaldehyde and the occurrence of anti-N-like cold agglutinins in RDT patients. Proc Eur Dial Transpl Assoc 13: 333, 1976

    Google Scholar 

  75. Crosson JT, Moulds J, Comty CM, Polesky HF: A clinical study of anti-NDP in the sera of patients in a large repetitive hemodialysis program. Kidney Int 10: 463, 1976

    Article  PubMed  CAS  Google Scholar 

  76. Berkes SL, Kahn SI, Chazan JA, Garella S: Prolonged hemolysis from overheated dialysate. Ann Intern Med 82: 363, 1975

    Google Scholar 

  77. Fortner RW, Nowakowski A, Carter CB, King LH Jr, Knepshield JH: Death due to overheated dialysate during dialysis. Ann Intern Med 73: 443, 1970

    PubMed  CAS  Google Scholar 

  78. Said R, Quintanilla A, Levin N, Ivanovich P: Acute hemolysis due to profound hyper-osmolality. A complication of hemodialysis. J Dial 1: 447, 1977

    PubMed  CAS  Google Scholar 

  79. Finch CA, Lenfant C: Oxygen transport in man. N Engl J Med 286: 407, 1972

    Article  PubMed  CAS  Google Scholar 

  80. Neff MS, Kim KE, Persoff M, Onesti G, Schwartz C: Hemodynamics of uremic anemia. Circulation 43: 876, 1971

    PubMed  CAS  Google Scholar 

  81. Perutz MF: Haem-Haem interaction and the problem of allostery. Nature 228: 726, 1970

    Article  PubMed  CAS  Google Scholar 

  82. Card RT, Brain MC: The ‘anemia’ of childhood. N Engl J Med 288: 388, 1973

    Article  PubMed  CAS  Google Scholar 

  83. Blumberg A, Keller G: Oxygen consumption during maintenance hemodialysis. Nephron 23: 276, 1979

    Article  PubMed  CAS  Google Scholar 

  84. Torrance JD, Milne FJ, Hurwitz SZ, Rabkin R: Changes in oxygen delivery during hemodialysis. Clin Nephrol 3: 53, 1975

    Google Scholar 

  85. Ahmad S, Pagel M, Shen F, Vizzo J, Scribner BH: The role of hypoxemia in the expression of acetate intolerance. Abstracts Am Soc Nephrol 13: 33A, 1980

    Google Scholar 

  86. Abu-Hamdan DK, Mahajan SK, Desai CW, Mueller B, Briggs WA, McDonald FD: Hypoxemia during bicarbonate dialysis. Abstracts Am Soc Nephrol 13:33 A, 1980

    Google Scholar 

  87. Craddock PR, Fehr J, Dalmasso AP, Brigham KL, Jacob HS: Hemodialysis leukopenia. Pulmonary vascular leukostasis resulting from complement activation by dialyzer cellophane membranes. J Clin Invest 59: 879, 1979

    Article  Google Scholar 

  88. Jacob AI, Gavellas G, Zarco R, Perez G, Bourgoignie JJ: Leukopenia, hypoxia, and complement function with different hemodialysis membranes. Kidney Int 18: 505, 1980

    Article  PubMed  CAS  Google Scholar 

  89. Aljama P, Bird PAE, Ward MK, Feest TG, Walker W, Tanboga H, Sussman M, Kerr DNS: Haemodialysis-induced leucopenia and activation of complement: Effects of different membranes. Proc Eur Dial Transpl Assoc 15: 144, 1978

    CAS  Google Scholar 

  90. Graefe U, Milutinovic J, Follette WC, Vizzo JE, Babb AL, Scribner BH: Less dialysis, induced morbidity and vascular instability with bicarbonate dialysate. Ann Intern Med 88: 332, 1978

    PubMed  CAS  Google Scholar 

  91. Tolchin N, Roberts JL, Hayashi J, Lewis EJ: Metabolic consequences of high mass-transfer hemodialysis. Kidney Int 11: 366, 1977

    Article  PubMed  CAS  Google Scholar 

  92. Jones RH, Broadfield JB, Parsons V: Arterial hypoxemia during hemodialysis for acute renal failure in mechanically ventilated patients: Observations and mechanisms. Clin Nephrol 14: 18, 1980

    PubMed  CAS  Google Scholar 

  93. Hirszel P, Maher JF, Tempel GE, Mengel CE: Influence of peritoneal dialysis on factors affecting oxygen transport. Nephron 15: 438, 1975

    Article  PubMed  CAS  Google Scholar 

  94. Stenzel KH, Cheigh JS, Sullivan JF, Tapia L, Riggio RR, Rubin AL: Clinical effects of bilateral nephrectomy. Am J Med 58: 69, 1975

    Article  PubMed  CAS  Google Scholar 

  95. Kominami N, Lowrie EG, Ianhez LE, Skaren A, Hampers CL, Merrill JP, Lange RD: The effect of total nephrectomy on hematopoiesis in patients undergoing chronic hemodialysis. J Lab Clin Med 78: 524, 1971

    PubMed  CAS  Google Scholar 

  96. Laurent C, Wittek M, Vereerstraeten P, Toussaint C, Naets JP: Red cells life span, splenic sequestration and transfusions requirements in chronic renal failure treated by hemodialysis. Effects of bilateral nephrectomy. Clin Nephrol 2: 35, 1974

    PubMed  CAS  Google Scholar 

  97. Van Ypersele de Strihou C, Stragier A: Effect of bilateral nephrectomy on transfusion requirements of patients undergoing chronic dialysis. Lancet 2: 705, 1969

    Article  PubMed  Google Scholar 

  98. Naets JP, Wittek M: Presence of erythropoietin in the plasma of one anephric patient. Blood 31: 249, 1968

    PubMed  CAS  Google Scholar 

  99. Avram MM, Alexis H, Rahman M, Son B, Iancu M: Decreased transfusional requirement following parathyroidectomy in long term hemodialysis. Abstracts Am Soc Nephrol 5: 5, 1971

    Google Scholar 

  100. Shasha SM, Better OS, Winaver J, Chaimovitz C, Barzilai A, Erlik D: Improvement in the anemia of hemodialyzed patients following subtotal parathyroidectomy. Isr J Med Sci 14: 328, 1978

    PubMed  CAS  Google Scholar 

  101. Zingraff J, Drueke T, Marie P, Man NK, Jungers P, Bordier P: Anemia and secondary hyperparathyroidism. Arch Intern Med 138: 1650, 1978

    Article  PubMed  CAS  Google Scholar 

  102. Barbour GL: Effect of parathyroidectomy on anemia in chronic renal failure. Arch Intern Med 139: 889, 1979

    Article  PubMed  CAS  Google Scholar 

  103. Meytes D, Bogin E, Ma A, Dukes PP, Massry SG: Effect of parathyroid hormone in erythropoiesis. J Clin Invest 67: 1263, 1981

    Article  PubMed  CAS  Google Scholar 

  104. Weinberg SG, Lubin A, Wiener S, Deoras MP, Ghose MK, Kopelman RC: Myelofibrosis and renal osteodystrophy. Am J Med 63: 755, 1977

    Article  PubMed  CAS  Google Scholar 

  105. Gurney CW, Jacobson LO, Goldwasser E: The physiologic and clinical significance of erythropoietin. Ann Intern Med 49: 363, 1958

    PubMed  CAS  Google Scholar 

  106. Kopple JD, Swendseid ME: Evidence that histidine is an essential amino acid in normal and chronically uremic man. J Clin Invest 55: 881, 1975

    Article  PubMed  CAS  Google Scholar 

  107. Giordano C, De Santo NG, Rinaldi S, Acone D, Esposito R, Gallo B: Histidine for treatment of uraemic anaemia. Br Med J 4: 714, 1973

    Article  PubMed  CAS  Google Scholar 

  108. Jontofsohn R, Heinze V, Katz N, Stuber U, Wilke H, Kluthe R: Histidine and iron supplementation in dialysis and pre-dialysis patients. Proc Eur Dial Transpl Assoc 11: 391, 1974

    Google Scholar 

  109. Reeves RD, Barbour GL, Robertson CS, Crumb CK: Failure of histidine supplementation to improve anemia in chronic dialysis patients. Am J Clin Nutr 30: 579, 1977

    PubMed  CAS  Google Scholar 

  110. Bischel MD, Neiman RS, Berne TV, Telfer N, Lukes RJ, Barbour BH: Hypersplenism in the uremic hemodialyzed patient. Nephron 9: 146, 1972

    Article  Google Scholar 

  111. Hartley LCJ, Morgan TO, Innis MD, Clunie CJA: Splenectomy for anaemia in patients on regular haemodialysis. Lancet 2: 1343, 1971

    Article  PubMed  CAS  Google Scholar 

  112. Ulan RA, Hill JR, Silverberg DS, Dawson ET, Dossetor JB: Erythrocyte survival and splenic sequestration in chronic dialysis patients. Abstracts Int Soc Nephrol 5: 27, 1972

    Google Scholar 

  113. Rosenmund A, Binswanger U, Straub PW: Oxidative injury to erythrocytes, cell rigidity, and splenic hemolysis in hemodialyzed uremic patients. Ann Intern Med 82: 460, 1975

    PubMed  CAS  Google Scholar 

  114. Asaba H, Bergstrom J, Lundgren G, Sorbo B, Tranaeus A, Zachrisson L: Hypersequestration of 51Cr-labelled erythrocytes as a criterion for splenectomy in regular hemodialysis patients. Clin Nephrol 8: 304, 1977

    PubMed  CAS  Google Scholar 

  115. Morgan T, Innes M, Ribush N: The management of the anaemia of patients on chronic haemodialysis. Med J Aust 1: 848, 1972

    PubMed  CAS  Google Scholar 

  116. Lichtman MA, Miller DR, Freeman RB: Erythrocyte adenosine triphosphate depletion during hypophosphatemia in a uremic subject. N Engl J Med 280: 240, 1969

    Article  PubMed  CAS  Google Scholar 

  117. Jacob HS, Amsden T: Acute hemolytic anemia with rigid red cells in hypophosphatemia. N Engl J Med 285: 1446, 1971

    Article  PubMed  CAS  Google Scholar 

  118. Baker LRI, Barnett MD, Brozovic B, Cattell WR, Ackrill P, McAlister J, Nimmon C: Hemosiderosis in a patient on regular hemodialysis: Treatment by desferrioxamine. Clin Nephrol 6: 326, 1976

    PubMed  CAS  Google Scholar 

  119. Pitts TO, Barbour GL: Hemosiderosis secondary to chronic parenteral iron therapy in maintenance hemodialysis patients. Nephron 22: 316, 1978

    Article  PubMed  CAS  Google Scholar 

  120. Schaefer AI, Cheron RG, Dluhy R, Cooper B, Gleason RE, Soeldner JS, Bunn HF: Clinical consequences of acquired transfusional iron overload in adults. N Engl J Med 304: 319, 1981

    Article  Google Scholar 

  121. Bregman H, Winchester JF, Knepshield JH, Gelfand MC, Manz HJ, Schreiner GE: Iron-overload-associated myopathy in patients on maintenance haemodialysis: A histocompatibility-linked disorder. Lancet 2: 882, 1980

    Article  PubMed  CAS  Google Scholar 

  122. Tisher CC, Barnett BMS, Finch CA, Scribner BH: Treatment of iron overload in patients with renal failure. Clin Sci 33: 539, 1967

    PubMed  CAS  Google Scholar 

  123. Kolk-Vegter AJ, Bosch E, van Leeuwen AM: Influence of serum hepatitis on haemoglobin level in patients on regular haemodialysis. Lancet 1: 526, 1971

    Article  PubMed  CAS  Google Scholar 

  124. Coleman JC, Eastwood JB, Curtis JE, Fox RA, Edwards MS: Hepatitis and epidemic hepatitis associated antigen in a haemodialysis unit with observations on haemoglobin levels. Br J Urol 44: 194, 1972

    Article  PubMed  CAS  Google Scholar 

  125. Simon P, Meyrier A, Tanquerel T, Ang K-S: Improvement of anaemia in haemodialysed patients after viral or toxic hepatic cytolysis. Br Med J 1: 892, 1980

    Article  Google Scholar 

  126. Brown S, Caro J, Erslev AJ, Murray TG: Spontaneous increase in erythropoietin and hematocrit value associated with transient liver enzyme abnormalities in an anephric patient undergoing hemodialysis. Am J Med 68: 280, 1980

    Article  PubMed  CAS  Google Scholar 

  127. Goldberg AP, Hagberg JM, Delmez JA, Carney RM, McKevitt PM, Harter HR: Metabolic effects of exercise training in hemodialysis patients. Proc 12th Annu Contractors’ Conf, Artif Kidney Program, NIAMDD, NIH Publ No 81-1979, 1981, edited by Mackey BB, p 7

    Google Scholar 

  128. Loge JP, Lange RD, Moore CV: Characterization of the anemia associated with chronic renal insufficiency. Am J Med 24: 4, 1958

    Article  PubMed  CAS  Google Scholar 

  129. Rastogi SP, Padilla F, Boyd CM: Effect of aluminium hydroxide on iron absorption. Abstracts Am Soc Nephrol 8: 21, 1975

    Google Scholar 

  130. Strickland ID, Chaput de Saintonge DM, Boulton FE, Francis B, Roubikova J, Water JI: The therapeutic equivalence of oral and intravenous iron in renal dialysis patients. Clin Nephrol 7: 55, 1977

    PubMed  CAS  Google Scholar 

  131. Parker PA, Izard MW, Maher JF: Therapy of iron deficiency anemia in patients on maintenance dialysis. Nephron 23: 181, 1979

    Article  PubMed  CAS  Google Scholar 

  132. Hamstra RD, Block MH, Schocket AL: Intravenous iron dextran in clinical medicine. JAMA 243: 1726, 1980

    Article  PubMed  CAS  Google Scholar 

  133. Kopple JD, Mercurio K, Blumenkrantz MJ, Jones MR, Tallos J, Roberts C, Card B, Saltzman R, Casciato DA, Swendseid ME: Daily requirement for pyridoxine supplements in chronic renal failure. Kidney Int 19: 694, 1981

    Article  PubMed  CAS  Google Scholar 

  134. Eschbach JW, Adamson JW: Improvement in the anemia of chronic renal failure with fluoxymesterone. Ann Intern Med 78: 527, 1973

    PubMed  CAS  Google Scholar 

  135. De Gowin RL, Lavender AR, Forland M, Charleston D, Gottschalk A: Erythropoiesis and erythropoietin in patients with chronic renal failure treated with hemodialysis and testosterone. Ann Intern Med 72: 913, 1970

    Google Scholar 

  136. Shaldon S, Koch KM, Oppermann F, Patyna WD: Testosterone therapy for anaemia in maintenance dialysis. Br Med J 3: 212, 1971

    Article  PubMed  CAS  Google Scholar 

  137. Fried W, Jonasson O, Lang G, Schwartz F: The hematologic effect of androgen in uremic patients. Study of packed cell volume and erythropoietin response. Ann Intern Med 79: 823, 1973

    PubMed  CAS  Google Scholar 

  138. Williams JS, Stein JH, Ferris TF: Nandrolene decanoate therapy for patients receiving hemodialysis. Arch Intern Med 134: 289, 1974

    Article  PubMed  CAS  Google Scholar 

  139. Hendler ED, Goffinet JA, Ross S, Longnecker RE, Bakovic V: Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis. N Engl J Med 291: 1046, 1974

    Article  PubMed  CAS  Google Scholar 

  140. von Hartitzsch B, Kerr DNS, Morley G, Marks B: Androgens in the anaemia of chronic renal failure. Nephron 18: 13, 1977

    Article  Google Scholar 

  141. Ball JH, Lowrie EG, Hampers CL, Merrill JP: Testosterone therapy in hemodialysis patients. Clin Nephrol 4: 91, 1975

    PubMed  CAS  Google Scholar 

  142. Mayer PP, Robinson BHB: Testosterone for anaemia in maintenance dialysis. Br Med J 2: 373, 1971

    Article  Google Scholar 

  143. Neff MS, Goldberg J, Slifkin RF, Eiser AR, Calamia V, Kaplan M, Baez A, Gupta S, Mattoo N: A comparison of androgens for anemia in patients on hemodialysis. N Engl J Med 304: 871, 1981

    Article  PubMed  CAS  Google Scholar 

  144. Radtke HW, Erbes PM, Schippers E, Koch KM: Serum erythropoietin concentration in anephric patients. Nephron 22: 361, 1978

    Article  PubMed  CAS  Google Scholar 

  145. Acchiardo SR, Black WD: Fluoxymesterone therapy in anemia of patients on maintenance hemodialysis: Comparison between patients with kidneys and anephric patients. J Dial 1: 357, 1977

    PubMed  CAS  Google Scholar 

  146. Singer JW, Adamson JW: Steroids and hematopoiesis. II. The effect of steroids on in vitro erythroid colony growth: Evidence for different target cells for different classes of steroids. J Cell Physiol 88: 135, 1976

    Article  PubMed  CAS  Google Scholar 

  147. Ahmad S, Shen F, Pagel M, Goodman W: Accelerated creatinine metabolism and elevated CPK with androgen therapy. Proc Clin Dial Transpl Forum 10: 174, 1980

    CAS  Google Scholar 

  148. Editorial (Anonymous). Androgens in the anaemia of chronic renal failure. Br Med J 2: 417, 1977

    Article  Google Scholar 

  149. Kalmanti M, Martino J, Callahan M, Dainiak N: Use of a clonal assay system to predict therapeutic response to steroids in the anemia of chronic renal failure. Kidney Int 19: 128, 1981

    Google Scholar 

  150. Curtis JR, Goode GC, Herrington J, Urdaneta LE: Possible cobalt toxicity in maintenance hemodialysis patients after treatment with cobaltous chloride: A study of blood and tissue cobalt concentrations in normal subjects and patients with terminal renal failure. Clin Nephrol 5: 61, 1976

    PubMed  CAS  Google Scholar 

  151. Editorial (anonymous): Cobalt in severe renal failure. Lancet 2: 26, 1976

    Google Scholar 

  152. Malgor LA, Blanc CC, Klainer E, Irizar, Torales PR, Barrios L: Direct effects of thyroid hormones on bone marrow erythroid cells of rats. Blood 45: 671, 1975

    PubMed  CAS  Google Scholar 

  153. Ferrer J, Diez-Ewald M, Garcia R, Rubio L, Rodriguez-Iturbe B: Effects of triiodothyronine on the anemia of chronic renal failure. Am J Hemat 5: 139, 1978

    Article  PubMed  CAS  Google Scholar 

  154. Bastow MD, Woods HF, Walls J: Persistent anemia associated with reduced serum vitamin B12 levels in patients undergoing regular hemodialysis therapy. Clin Nephrol 11: 133, 1979

    PubMed  CAS  Google Scholar 

  155. Fried W: Anemia in patients with chronic renal failure. Int J Artif Organs 3: 62, 1980

    PubMed  CAS  Google Scholar 

  156. Opelz G, Terasaki PI: Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med 299: 799, 1978

    Article  PubMed  CAS  Google Scholar 

  157. Vincenti F, Duca RM, Amend W, Perkins HA, Cochrum KC, Feduska NJ, Salvatierra O Jr: Immunologic factors determining survival of cadaver kidney transplants. N Engl J Med 299: 793, 1978

    Article  PubMed  CAS  Google Scholar 

  158. Storb R, Thomas ED, Buckner CD, Clift RA, Deeg HJ, Fefer A, Goodell BW, Sale GE, Sanders JE, Singer J, Stewart P, Weiden PL: Marrow transplantation in thirty ‘untransfused’ patients with severe aplastic anemia. Ann Intern Med 92: 30, 1980

    PubMed  CAS  Google Scholar 

  159. Albrechtsen D, Bratlie A, Kiss E, Solheim BG, Thoresen AB, Wither N, Thorsby E: Significance of HLA matching in renal transplantation. Transplantation 28: 280, 1979

    Article  PubMed  CAS  Google Scholar 

  160. Myhre BA: Fatalities from blood transfusion. JAMA 244: 1333, 1980

    Article  PubMed  CAS  Google Scholar 

  161. Pineda AA, Brzica SM, Taswell HF: Hemolytic transfusion reaction: A recent experience in a large blood bank. Mayo Clin Proc 53: 378, 1978

    PubMed  CAS  Google Scholar 

  162. Horowitz HI, Stein IM, Cohen BD, White JG: Further studies on the platelet-inhibitory effect of guanidinosuc- cinic acid and its role in uremic bleeding. Am J Med 49: 336, 1970

    Article  PubMed  CAS  Google Scholar 

  163. Rabiner SF, Molinas F: The role of phenol and phenolic acids on the thrombocytopathy and defective platelet aggregation of patients with renal failure. Am J Med 49:-346, 1970

    Google Scholar 

  164. Huebsch LB, Harker LA: Disorders of platelet function. Western J Med 134: 109, 1981

    CAS  Google Scholar 

  165. Shattil SJ, Bennett JS: Platelets and their membranes in hemostasis: physiology and pathophysiology. Ann Intern Med 94: 108, 1981

    PubMed  CAS  Google Scholar 

  166. Salzman EW, Neri LL: Adhesiveness of blood platelets in uremia. Thromb Diath Haemorrh 15: 84, 1966

    PubMed  CAS  Google Scholar 

  167. Harker LA, Slichter SJ: The bleeding time as a screening test for evaluation of platelet function. N Engl J Med 287: 155, 1972

    Article  PubMed  CAS  Google Scholar 

  168. Remuzzi G, Livio M, Marchiaro G, Mecca G, de Gaetano G: Bleeding in renal failure: Altered platelet function in chronic uremia only partially corrected by haemodialysis. Nephron 22: 347, 1978

    Article  PubMed  CAS  Google Scholar 

  169. Lindsay RM, Moorthy AV, Koens F, Linton AL: Platelet function in dialyzed and non-dialyzed patients with chronic renal failure. Clin Nephrol 4: 52, 1975

    PubMed  CAS  Google Scholar 

  170. Lindsay RM, Friesen M, Koens F, Linton AL, Oreopoulos DG, de Veber G: Platelet function in patients on long term peritoneal dialysis. Clin Nephrol 6: 335, 1976

    PubMed  CAS  Google Scholar 

  171. Lindsay RM, Friesen M, Aronstam A, Andrus F, Clark WF, Linton AL: Improvement of platelet function by increased frequency of hemodialysis. Clin Nephrol 10: 67, 1978

    PubMed  CAS  Google Scholar 

  172. Jorenson KA, Ingeberg S: Platelets and platelet function in patients with chronic uremia on maintenance hemodialysis. Nephron 23: 233, 1979

    Article  Google Scholar 

  173. Wathen R, Smith M, Keshaviah P, Comty C, Shapiro F: Depressed in vitro aggregation of platelets of chronic hemodialysis patients: A role for cyclic amp. Trans Am Soc Artif Int Organs 21: 320, 1975

    CAS  Google Scholar 

  174. Janson PA, Jubelirer SJ, Weinstein MJ, Deykin D: Treatment of the bleeding tendency in uremia with cryoprecipitate. N Engl J Med 303: 1318, 1980

    Article  PubMed  CAS  Google Scholar 

  175. Tenckhoff H: Chronic Peritoneal Dialysis Manual University of Washington, Seattle, Washington, 1974

    Google Scholar 

  176. Lindsay RM, Prentice CRM, Davidson JF, Burton JA, McNicol GP: Haemostatic changes during dialysis associated with thrombus formation on dialysis membranes. Br Med J 2: 454, 1972

    Article  Google Scholar 

  177. Rucinski B, Niewiarowski S, James P, Walz DA, Budzynski AZ: Antiheparin proteins secreted by human platelets. Purification, characterization, and radioimmunoassay. Blood 53: 47, 1969.

    Google Scholar 

  178. Aronstam A, Dennis B, Friesen MJ, Clark WF, Linton AL, Lindsay RM: Heparin neutralizing activity in patients with renal disease on maintenance hemodialysis. Thromb Haemost 39: 695, 1978

    PubMed  CAS  Google Scholar 

  179. Lindsay RM: Variable heparin requirements during hemodialysis — Why? asaio J 3: 81, 1980

    Google Scholar 

  180. Turney JH, Fewell MR, Williams LC, Parsons V, Weston MJ: Platelet protection and heparin sparing with prostacyclin during regular dialysis therapy. Lancet 2: 219, 1980

    Article  PubMed  CAS  Google Scholar 

  181. Zusman RM, Rubin RH, Cato AE, Cocchetto DM, Crow JW, Tolkofif-Rubin N: Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med 304: 934, 1981

    Article  PubMed  CAS  Google Scholar 

  182. Lindsay RM, Ferguson D, Prentice CRM, Burton JA, McNicol GP: Reduction of thrombus formation on dia- lyser membranes by aspirin and RA 233. Lancet 2: 1287, 1972

    Article  PubMed  CAS  Google Scholar 

  183. Harter HR, Burch JW, Majerus PW, Stanford N, Delmez J A, Anderson CB, Weerts C: Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med 301: 577, 1979

    Article  PubMed  CAS  Google Scholar 

  184. Kaegi A, Pineo GF, Shimizu A, Trivedi H, Hirsh J, Gent M: Arteriovenous-shunt thrombosis. N Engl J Med 290: 304, 1974

    Article  PubMed  CAS  Google Scholar 

  185. Hoy WE, Cestero RYM, Freeman RB: Deficiency of T and B lymphocytes in uremic subjects and partial improvement with maintenance hemodialysis. Nephron 20: 182, 1978

    Article  PubMed  CAS  Google Scholar 

  186. Harris J, Sengar D, Rashid A, Hyslop D, Green L: Immunodeficiency in chronic uremia: Preliminary evidence for thymosin deficiency. Transplantation 20: 176, 1975

    Article  PubMed  CAS  Google Scholar 

  187. Hosking CS, Atkins RC, Scott DF, Holdsworth SR, Fitzgerald MG, Shelton MJ: Immune and phagocytic functions in patients on maintenance dialysis and post-transplantation. Clin Nephrol 6: 501, 1976

    PubMed  CAS  Google Scholar 

  188. Goldblum SE, Reed WP: Host defenses and immunologic alterations associated with chronic hemodialysis. Ann Intern Med 93: 597, 1980

    CAS  Google Scholar 

  189. Dale DC: Neutrophils and the acute inflammatory response in chronic renal failure. Dial Transpl 8: 314, 1979

    Google Scholar 

  190. Salont DJ, Glover A, Anderson R, Meyers AM, Rabkin R, Myburgh JA, Rabson AR: Depressed neutrophil Chemotaxis in patients with chronic renal failure and after renal transplantations. J Lab Clin Med 88: 536, 1976

    Google Scholar 

  191. Greene WH, Ray C, Mauer SM, Quie PG: The effect of hemodialysis on neutrophil chemotactic responsiveness. J Lab Clin Med 88: 971, 1976

    PubMed  CAS  Google Scholar 

  192. Kaplow LS, Goffinet JA: Profound neutropenia during the early phase of hemodialysis. JAMA 203: 1135, 1968

    Article  PubMed  CAS  Google Scholar 

  193. Gral T, Schroth P, DePalma JR, Gordon A: Leukocyte dynamics with three types of hemodialyzers. Trans Am Soc Artif Intern Organs 15: 45, 1969

    PubMed  CAS  Google Scholar 

  194. Brubaker LH, Nolph KD: Mechanisms of recovery from neutropenia induced by hemodialysis. Blood 38: 623, 1971

    PubMed  CAS  Google Scholar 

  195. Savdie E, Bruce L, Vincent PC: Modified neutropenic response to re-used dialyzers in patients with chronic renal failure. Clin Nephrol 8: 422, 1977

    PubMed  CAS  Google Scholar 

  196. Jacob HS, Craddock PR, Hammerschmidt DE, Moldow CF: Complement-induced granulocyte aggregation. An unsuspected mechanism of disease. N Engl J Med 302: 789, 1980

    Article  PubMed  CAS  Google Scholar 

  197. Dumler F, Levin NW: Unrelated effects of hemodialysis. Arch Intern Med 139: 1103, 1979

    Article  PubMed  CAS  Google Scholar 

  198. Toren M, Goffinet JA, Kaplow LS: Pulmonary bed sequestration of neutrophils during hemodialysis. Blood 36: 337, 1970

    PubMed  CAS  Google Scholar 

  199. Conger JD, Hammond WS, Alfrey AC, Contiguglia SR, Stanford RE, Huffer WE: Pulmonary calcification in chronic dialysis patients: Clinical and pathologic studies. Ann Intern Med 83: 330, 1975

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Joseph W. Eschbach
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine Queen Wilhelmina University Hospital, Amsterdam, The Netherlands

    William Drukker M.D. (Formerly Reader in Dialysis, Emeritus Director Department of Nephrology and Dialysis) (Formerly Reader in Dialysis, Emeritus Director Department of Nephrology and Dialysis)

  2. St. Lucas Hospital, Amsterdam, Netherlands

    William Drukker M.D. (Formerly Reader in Dialysis, Emeritus Director Department of Nephrology and Dialysis) (Formerly Reader in Dialysis, Emeritus Director Department of Nephrology and Dialysis)

  3. De Lairessestraat 75, 1071 NV, Amsterdam, The Netherlands

    William Drukker M.D. (Formerly Reader in Dialysis, Emeritus Director Department of Nephrology and Dialysis) (Formerly Reader in Dialysis, Emeritus Director Department of Nephrology and Dialysis)

  4. Renal Research Unit, Wellcome Wing, The General Infirmary at Leeds, LS1 3EX, Leeds, England

    Frank M. Parsons B.Sc., M.D., F.R.C.P. Ed. (Consultant Physician in Clinical Renal Physiology, Senior Clinical Lecturer in Medicine) (Consultant Physician in Clinical Renal Physiology, Senior Clinical Lecturer in Medicine)

  5. University of Leeds, England

    Frank M. Parsons B.Sc., M.D., F.R.C.P. Ed. (Consultant Physician in Clinical Renal Physiology, Senior Clinical Lecturer in Medicine) (Consultant Physician in Clinical Renal Physiology, Senior Clinical Lecturer in Medicine)

  6. Nephrology Division, Uniformed Services University of the Health Sciences School of Medicine, 4301 Jones Bridge Road, Bethesda, MD, 20814, USA

    John F. Maher M.D. (Professor of Medicine, Director) (Professor of Medicine, Director)

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Martinus Nijhoff Publishers, Dordrecht

About this chapter

Cite this chapter

Eschbach, J.W. (1983). Hematologic Problems of Dialysis Patients. In: Drukker, W., Parsons, F.M., Maher, J.F. (eds) Replacement of Renal Function by Dialysis. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-6768-7_32

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-6768-7_32

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-0-89838-770-4

  • Online ISBN: 978-94-009-6768-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation